BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31267263)

  • 1. GNAS-AS1/miR-4319/NECAB3 axis promotes migration and invasion of non-small cell lung cancer cells by altering macrophage polarization.
    Li Z; Feng C; Guo J; Hu X; Xie D
    Funct Integr Genomics; 2020 Jan; 20(1):17-28. PubMed ID: 31267263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA FEZF1-AS1 promotes non-small lung cancer cell migration and invasion through the up-regulation of NOTCH1 by serving as a sponge of miR-34a.
    Huang S; Li C; Huang J; Luo P; Mo D; Wang H
    BMC Pulm Med; 2020 Apr; 20(1):110. PubMed ID: 32349744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of long non-coding RNA ZEB2-AS1 may predict poor prognosis and promote the migration, invasion, and epithelial-mesenchymal transition of tumor cells in non-small cell lung cancer.
    Xu H; Yu B; Shen W; Jin C; Wang L; Xi Y
    Int J Biol Markers; 2020 Sep; 35(3):29-35. PubMed ID: 32611283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA CALML3-AS1 modulated by m
    Zhang H; Wang SQ; Zhu JB; Wang LN; Lin H; Li LF; Cheng YD; Duan CJ; Zhang CF
    Cancer Gene Ther; 2023 Dec; 30(12):1649-1662. PubMed ID: 37884580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-HOXC-AS2 regulates tumor-associated macrophage polarization through the STAT1/SOCS1 and STAT1/CIITA pathways to promote the progression of non-small cell lung cancer.
    Yin C; Li J; Li S; Yang X; Lu Y; Wang C; Liu B
    Cell Signal; 2024 Mar; 115():111031. PubMed ID: 38168631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HHLA2 deficiency inhibits non-small cell lung cancer progression and THP-1 macrophage M2 polarization.
    Sun W; Li S; Tang G; Sun S; Luo Y; Bai R; Han L; Jiang X; Gao Y; Huang Z; Zhang J; Gong Y; Xie C
    Cancer Med; 2021 Aug; 10(15):5256-5269. PubMed ID: 34152094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA ZNF674-AS1 regulates miR-23a/E-cadherin axis to suppress the migration and invasion of non-small cell lung cancer cells.
    Wang J; Liu S; Pan T; Wang M; Li L; Weng X; Jia P; Li Q; Zhou X
    Transl Cancer Res; 2021 Sep; 10(9):4116-4124. PubMed ID: 35116709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA RGMB-AS1 inhibits HMOX1 ubiquitination and NAA10 activation to induce ferroptosis in non-small cell lung cancer.
    Gao GB; Chen L; Pan JF; Lei T; Cai X; Hao Z; Wang Q; Shan G; Li J
    Cancer Lett; 2024 May; 590():216826. PubMed ID: 38574881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CtBP1 promotes tumour-associated macrophage infiltration and progression in non-small-cell lung cancer.
    Wang Z; Zhao Y; Xu H; Liang F; Zou Q; Wang C; Jiang J; Lin F
    J Cell Mol Med; 2020 Oct; 24(19):11445-11456. PubMed ID: 32910558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentinan inhibits cell invasion via M2 polarization of tumor-associated macrophages and Wnt/β-catenin signaling in non-small cell lung cancer.
    Yang Y; Cheng Y; Mu Y; Tang X; Mu X
    Chem Biol Drug Des; 2024 Mar; 103(3):e14507. PubMed ID: 38538070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PURPL Promotes M2 Macrophage Polarization in Lung Cancer by Regulating RBM4/xCT Signaling.
    Guo J; Gong C; Wang H
    Crit Rev Eukaryot Gene Expr; 2024; 34(5):59-68. PubMed ID: 38842204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of CHP2 in the Development of Non-Small Cell Lung Cancer and Patients' Poor Prognosis.
    Xu L; Qin Y; Sun B; Wang H; Gu J; Tang Z; Zhang W; Feng J
    Appl Immunohistochem Mol Morphol; 2020 Oct; 28(9):678-686. PubMed ID: 33030853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell RNA sequencing reveals aberrant sphingolipid metabolism in non-small cell lung cancer impacts tumor-associated macrophages and stimulates angiogenesis via macrophage inhibitory factor signaling.
    Shen L; Liu J; Hu F; Fang Y; Wu Y; Zhao W; Ma S
    Thorac Cancer; 2024 May; 15(14):1164-1175. PubMed ID: 38587042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages.
    Wei X; Nie S; Liu H; Sun J; Liu J; Li J; Li S; Wang S; Han S; Wang J; Sun Y
    Am J Cancer Res; 2017; 7(11):2220-2233. PubMed ID: 29218246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis.
    Liang Y; Song X; Li Y; Chen B; Zhao W; Wang L; Zhang H; Liu Y; Han D; Zhang N; Ma T; Wang Y; Ye F; Luo D; Li X; Yang Q
    Mol Cancer; 2020 May; 19(1):85. PubMed ID: 32384893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.
    Liu SQ; Zhou ZY; Dong X; Guo L; Zhang KJ
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32538432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization.
    Liang ZX; Liu HS; Wang FW; Xiong L; Zhou C; Hu T; He XW; Wu XJ; Xie D; Wu XR; Lan P
    Cell Death Dis; 2019 Nov; 10(11):829. PubMed ID: 31685807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA NEAT1 sponges miR-214 to regulate M2 macrophage polarization by regulation of B7-H3 in multiple myeloma.
    Gao Y; Fang P; Li WJ; Zhang J; Wang GP; Jiang DF; Chen FP
    Mol Immunol; 2020 Jan; 117():20-28. PubMed ID: 31731055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling.
    Tian X; Wu Y; Yang Y; Wang J; Niu M; Gao S; Qin T; Bao D
    Mol Oncol; 2020 Feb; 14(2):462-483. PubMed ID: 31785055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways.
    Qian M; Wang S; Guo X; Wang J; Zhang Z; Qiu W; Gao X; Chen Z; Xu J; Zhao R; Xue H; Li G
    Oncogene; 2020 Jan; 39(2):428-442. PubMed ID: 31485019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.